These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 15812078

  • 1. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.
    J Natl Cancer Inst; 2005 Apr 06; 97(7):525-32. PubMed ID: 15812078
    [Abstract] [Full Text] [Related]

  • 2. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 2007 Oct 06; 16(10):1982-9. PubMed ID: 17932345
    [Abstract] [Full Text] [Related]

  • 3. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE, Chang B, Liu W, Li T, Turner AR, Li L, Li G, Adami HO, Isaacs WB, Xu J, Grönberg H.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar 06; 15(3):480-5. PubMed ID: 16537705
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C, Lindström S, Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Grönberg H.
    Clin Cancer Res; 2006 Mar 15; 12(6):1936-41. PubMed ID: 16551880
    [Abstract] [Full Text] [Related]

  • 5. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ.
    Cancer Res; 2005 Dec 15; 65(24):11771-8. PubMed ID: 16357190
    [Abstract] [Full Text] [Related]

  • 6. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
    Lindmark F, Zheng SL, Wiklund F, Bensen J, Bälter KA, Chang B, Hedelin M, Clark J, Stattin P, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J.
    J Natl Cancer Inst; 2004 Aug 18; 96(16):1248-54. PubMed ID: 15316060
    [Abstract] [Full Text] [Related]

  • 7. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
    Lindström S, Wiklund F, Adami HO, Bälter KA, Adolfsson J, Grönberg H.
    Cancer Res; 2006 Nov 15; 66(22):11077-83. PubMed ID: 17108148
    [Abstract] [Full Text] [Related]

  • 8. Toll-like receptor heterodimer variants protect from childhood asthma.
    Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J, Vogelberg C, Weiland SK, von Mutius E, Kabesch M.
    J Allergy Clin Immunol; 2008 Jul 15; 122(1):86-92, 92.e1-8. PubMed ID: 18547625
    [Abstract] [Full Text] [Related]

  • 9. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
    Stevens VL, Hsing AW, Talbot JT, Zheng SL, Sun J, Chen J, Thun MJ, Xu J, Calle EE, Rodriguez C.
    Int J Cancer; 2008 Dec 01; 123(11):2644-50. PubMed ID: 18752252
    [Abstract] [Full Text] [Related]

  • 10. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.
    Veltkamp M, van Moorsel CH, Rijkers GT, Ruven HJ, Grutters JC.
    Tissue Antigens; 2012 Jan 01; 79(1):25-32. PubMed ID: 22150367
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10.
    Opsal MA, Våge DI, Hayes B, Berget I, Lien S.
    Gene; 2006 Dec 15; 384():45-50. PubMed ID: 16950576
    [Abstract] [Full Text] [Related]

  • 13. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I, Plummer SJ, Casey G, Witte JS.
    Cancer Epidemiol Biomarkers Prev; 2007 Feb 15; 16(2):352-5. PubMed ID: 17301271
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
    Xu J, Lowey J, Wiklund F, Sun J, Lindmark F, Hsu FC, Dimitrov L, Chang B, Turner AR, Liu W, Adami HO, Suh E, Moore JH, Zheng SL, Isaacs WB, Trent JM, Grönberg H.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov 15; 14(11 Pt 1):2563-8. PubMed ID: 16284379
    [Abstract] [Full Text] [Related]

  • 18. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C, González-Escribano MF, Diaz-Gallo LM, Lucena-Soto JM, Márquez JL, Leo E, Crivell C, Gómez-García M, Martín J, Núñez-Roldán A, García-Lozano JR.
    Genes Immun; 2011 Dec 15; 12(8):635-42. PubMed ID: 21716313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma.
    Tantisira K, Klimecki WT, Lazarus R, Palmer LJ, Raby BA, Kwiatkowski DJ, Silverman E, Vercelli D, Martinez FD, Weiss ST.
    Genes Immun; 2004 Aug 15; 5(5):343-6. PubMed ID: 15266299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.